The Hon’ble High Court of Delhi in a recent judgement, FMC Corporation v. Natco Pharma Limited interpreted the doctrine of equivalents in the light of patent law in India and contributed to the grow...
Published On: 31/01/2019
Practice Area: Dispute Resolution, Intellectual Property
Authors:
Sandeep Grover
Kshitij Parashar
On January 8, 2019, the Supreme Court over-ruled a decision of the Delhi High Court, which held that Monsanto's patent for technology to genetically modify hybrid seeds was unpatentable, on the grounds that it had not sufficiently examined the question of patentability to the required standard, in reaching such a decision. INDUSLAW's Sandeep Grover and Kshitij Parashar discuss and analyse this judgment.
